search
Back to results

Biofeedback Treatment of Anxiety Associated With Chronic Spinal Cord Injury

Primary Purpose

Spinal Cord Injuries, Anxiety, Stress

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Psychophysiological monitoring
Biofeedback training
Sponsored by
Craig Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Spinal Cord Injuries

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Age 18 to 65
  • Diagnosis of tetraplegia with residual sensory or motor impairments
  • Discharged from inpatient rehabilitation and living in the community
  • Access to high-speed internet at home
  • Willingness to download the videoconferencing software Zoom
  • Access to a mobile phone and willingness to download HRV software

Exclusion Criteria:

  • Does not speak English
  • Scores less than 37 on the STAI
  • Unable to travel to Craig for an initial assessment
  • History of participating in biofeedback training
  • Requires mechanical ventilation
  • Dependent on diaphragm pacer for respiration
  • Currently in treatment for anxiety (e.g., pharmacologic or psychotherapeutic)
  • Associated medical condition for which biofeedback is contraindicated (e.g., psychosis, pacemaker, or other implantable electric device)
  • Currently hospitalized for medical/rehabilitation treatment
  • Unable to commit to the four-week intervention

Sites / Locations

  • Craig Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Biofeedback

Control Group

Arm Description

Participants (n=15) will undergo 30 minutes of self-administered 1-channel (ECG) physiological monitoring at home using the Mindfield eSense Pulse twice a week for four weeks (eight sessions in total). The biofeedback training session will be conducted using the eSense Pulse smartphone application. Participants will receive further instruction explaining how physiological information will be displayed and used as a means of training to induce a relaxed state while receiving real time feedback. Participants will be instructed on using controlled breathing to assist with reaching this relaxed state. Prior to each training session, the Study Coordinator will meet with the participant via Zoom to virtually assist with setup. Following each training session, participants will respond to questionnaires over the phone.

Participants (n=15) will undergo 30 minutes of self-administered 1-channel (ECG) physiological monitoring at home using the Mindfield eSense Pulse twice a week for four weeks (eight sessions in total). Participants will be provided with the following instructions: "You will be monitored with this equipment for 30 minutes. During this time frame, please try to limit movement and conversation as much as possible." Prior to each training session, the Study Coordinator will meet with the participant via Zoom to virtually assist with setup. Following each training session, participants will respond to questionnaires over the phone.

Outcomes

Primary Outcome Measures

Change in physiological stress
Average LF (ms2)
Change in Depression Anxiety Stress Scale-21 (DASS-21) scores
The Depression Anxiety Stress Scale-21 (DASS-21) is a self report instrument designed to measure core symptoms of depression, anxiety, and stress. Each of the three DASS-21 scales contains seven items, divided into subscales with similar content. Scores for depression, anxiety, and stress are calculated by summing the scores for the relevant items. Items are rated on a scale from 0 (did not apply to me at all) to 3 (applied to me very much or most of time), with higher scores indicating more depression, anxiety, and stress.
Change in Subjective Units of Distress Scale (SUDS) scores
The Subjective Units of Distress Scale (SUDS) is a single-item self report instrument designed to measure the intensity of feelings and other internal experiences such as anxiety, anger, agitation, stress, or other painful feelings. A scale of 0 to 100 will be used to measure the subjective intensity of disturbance or distress experienced by the participant. A higher score indicates greater distress.

Secondary Outcome Measures

Symptom list
A list of self-reported symptoms will be used to track any new symptoms requiring medical attention that emerge during the course of the study.
State Trait Anxiety Inventory (STAI)
The State Trait Anxiety Inventory (STAI) is a 40 item self-report inventory consisting of 20 items to assess trait anxiety and 20 items to assess state anxiety. Items are rated on a scale from 1 (not at all) to 4 (very much). A total score is calculated by summing all six scores, multiplying the sum by 20, and then dividing by six. Total scores range from 20 - 80 with higher scores indicating greater self-reported anxiety. A normal score on the STAI is 34 - 36.

Full Information

First Posted
May 16, 2019
Last Updated
April 24, 2023
Sponsor
Craig Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03975075
Brief Title
Biofeedback Treatment of Anxiety Associated With Chronic Spinal Cord Injury
Official Title
Biofeedback Treatment of Anxiety Associated With Chronic Spinal Cord Injury
Study Type
Interventional

2. Study Status

Record Verification Date
April 2023
Overall Recruitment Status
Completed
Study Start Date
October 1, 2019 (Actual)
Primary Completion Date
January 31, 2023 (Actual)
Study Completion Date
January 31, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Craig Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this research is to test the feasibility of an intervention using biofeedback to treat stress and anxiety among individuals with tetraplegia. The expected duration of participation in this study is about 5 hours over the course of about 5 weeks. Participants will be randomly assigned to either a biofeedback training intervention or a control group. After completing questionnaires, participants will undergo physiological monitoring for the purpose of measuring heart rate and breathing. Those assigned to the biofeedback group will undergo 20 minutes of physiological monitoring while also participating in biofeedback training twice a week for 4 weeks (8 sessions) from home. Those assigned to the control group will undergo 20 minutes of physiological monitoring twice a week for 4 weeks (8 sessions) from home, but will not receive biofeedback training. Each session is expected to last 30 minutes to allow for completion of questionnaires over the the phone prior to and following each training session. It is hypothesized that the biofeedback intervention will demonstrate high feasibility and compared to those in the control group, participants who receive the biofeedback intervention will attain greater pre-post reductions in both physiological and self-reported stress.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Spinal Cord Injuries, Anxiety, Stress, Tetraplegia

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Biofeedback
Arm Type
Experimental
Arm Description
Participants (n=15) will undergo 30 minutes of self-administered 1-channel (ECG) physiological monitoring at home using the Mindfield eSense Pulse twice a week for four weeks (eight sessions in total). The biofeedback training session will be conducted using the eSense Pulse smartphone application. Participants will receive further instruction explaining how physiological information will be displayed and used as a means of training to induce a relaxed state while receiving real time feedback. Participants will be instructed on using controlled breathing to assist with reaching this relaxed state. Prior to each training session, the Study Coordinator will meet with the participant via Zoom to virtually assist with setup. Following each training session, participants will respond to questionnaires over the phone.
Arm Title
Control Group
Arm Type
Active Comparator
Arm Description
Participants (n=15) will undergo 30 minutes of self-administered 1-channel (ECG) physiological monitoring at home using the Mindfield eSense Pulse twice a week for four weeks (eight sessions in total). Participants will be provided with the following instructions: "You will be monitored with this equipment for 30 minutes. During this time frame, please try to limit movement and conversation as much as possible." Prior to each training session, the Study Coordinator will meet with the participant via Zoom to virtually assist with setup. Following each training session, participants will respond to questionnaires over the phone.
Intervention Type
Behavioral
Intervention Name(s)
Psychophysiological monitoring
Intervention Description
30 minutes of one channel (ECG) physiological monitoring with Mindfield eSense Pulse.
Intervention Type
Behavioral
Intervention Name(s)
Biofeedback training
Intervention Description
Traditional resonance frequency training with the Mindfield eSense Pulse smartphone application. Using visual feedback of real time parameters of HRV and the use of controlled breathing, participants are trained to reach a relaxed state.
Primary Outcome Measure Information:
Title
Change in physiological stress
Description
Average LF (ms2)
Time Frame
Session #1 (week 1) and Session #8 (week 4)
Title
Change in Depression Anxiety Stress Scale-21 (DASS-21) scores
Description
The Depression Anxiety Stress Scale-21 (DASS-21) is a self report instrument designed to measure core symptoms of depression, anxiety, and stress. Each of the three DASS-21 scales contains seven items, divided into subscales with similar content. Scores for depression, anxiety, and stress are calculated by summing the scores for the relevant items. Items are rated on a scale from 0 (did not apply to me at all) to 3 (applied to me very much or most of time), with higher scores indicating more depression, anxiety, and stress.
Time Frame
Baseline (week 0) and Session #8 (week 4)
Title
Change in Subjective Units of Distress Scale (SUDS) scores
Description
The Subjective Units of Distress Scale (SUDS) is a single-item self report instrument designed to measure the intensity of feelings and other internal experiences such as anxiety, anger, agitation, stress, or other painful feelings. A scale of 0 to 100 will be used to measure the subjective intensity of disturbance or distress experienced by the participant. A higher score indicates greater distress.
Time Frame
Baseline (week 0) and Session #8 (week 4)
Secondary Outcome Measure Information:
Title
Symptom list
Description
A list of self-reported symptoms will be used to track any new symptoms requiring medical attention that emerge during the course of the study.
Time Frame
After intervention session #1 (week 1), before and after intervention sessions #2-8 (weeks 1 through 4)
Title
State Trait Anxiety Inventory (STAI)
Description
The State Trait Anxiety Inventory (STAI) is a 40 item self-report inventory consisting of 20 items to assess trait anxiety and 20 items to assess state anxiety. Items are rated on a scale from 1 (not at all) to 4 (very much). A total score is calculated by summing all six scores, multiplying the sum by 20, and then dividing by six. Total scores range from 20 - 80 with higher scores indicating greater self-reported anxiety. A normal score on the STAI is 34 - 36.
Time Frame
After intervention sessions #1-8 (weeks 1 through 4)
Other Pre-specified Outcome Measures:
Title
Brief Pain Inventory (BPI) - 4 pain severity items
Description
The Brief Pain Inventory (BPI) is one of the most widely used tools to assess pain. For this study, the four pain severity items will be used to assess worst, least, average, and current pain.
Time Frame
Baseline (week 0) and Session #8 (week 4)
Title
Brief Pain Inventory (BPI) - current pain severity item
Description
A single item from the Brief Pain Inventory (BPI) will be used to assess the severity of current pain.
Time Frame
Before and after intervention Sessions #1-7 (weeks 1 - 3)
Title
Brief Pain Inventory (BPI) - pain relief item
Description
A single item from the Brief Pain Inventory (BPI) has been modified from, "In the last 24 hours, how much relief have pain treatments or medications provided? Please mark the box below the percentage that most shows how much relief you have received" to read, "During this session, how much pain relief did you experience? Please indicate the percentage that best describes how much relief you received."
Time Frame
After each intervention Session #1-8 (weeks 1 - 4)
Title
Impact of study participation
Description
Impact of Study Participation is a single open-ended item used to determine if study participation impacted anything other than stress, anxiety, or pain. Following the final session, participants will be asked, "Are there conditions other than stress, anxiety, or pain that were impacted by your participation in this study? If so, please list."
Time Frame
Session #8 (week 4)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age 18 to 65 Diagnosis of tetraplegia with residual sensory or motor impairments Discharged from inpatient rehabilitation and living in the community Access to high-speed internet at home Willingness to download the videoconferencing software Zoom Access to a mobile phone and willingness to download HRV software Exclusion Criteria: Does not speak English Scores less than 37 on the STAI Unable to travel to Craig for an initial assessment History of participating in biofeedback training Requires mechanical ventilation Dependent on diaphragm pacer for respiration Currently in treatment for anxiety (e.g., pharmacologic or psychotherapeutic) Associated medical condition for which biofeedback is contraindicated (e.g., psychosis, pacemaker, or other implantable electric device) Currently hospitalized for medical/rehabilitation treatment Unable to commit to the four-week intervention
Facility Information:
Facility Name
Craig Hospital
City
Englewood
State/Province
Colorado
ZIP/Postal Code
80113
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Biofeedback Treatment of Anxiety Associated With Chronic Spinal Cord Injury

We'll reach out to this number within 24 hrs